| 3R0T: reference: Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical stage for the treatment of cancer., Battistutta R, Cozza G, Pierre F, Papinutto E, Lolli G, Sarno S, O'Brien SE, Siddiqui-Jain A, Haddach M, Anderes K, Ryckman DM, Meggio F, Pinna LA, Biochemistry. 2011 Aug 26. PMID: 21870818 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).